ELAN|Elanco Animal Health Inc|Preço:23.650|Var. %:-0.36

Mais detalhes de Elanco Animal Health Inc Empresa

Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.

Informações de Elanco Animal Health Inc



Código da empresaELAN

Nome da EmpresaElanco Animal Health Inc

Data de listagemSep 20, 2018

CEOSimmons (Jeffrey N)

Número de funcionários9000

Tipo de títulosOrdinary Share

Fim do ano fiscalSep 20

Endereço450 Elanco Circle

CidadeINDIANAPOLIS

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísUnited States of America

Código postal46221

Telefone18773526261

Sitehttps://www.elanco.com/

Código da empresaELAN

Data de listagemSep 20, 2018

CEOSimmons (Jeffrey N)

Executivos da empresa Elanco Animal Health Inc



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

3.25M

+27.46%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

229.43K

+10.35%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

170.34K

--

Mr. Timothy J. (Tim) Bettington

Executive Vice President - Corporate Strategy and Market Development

158.49K

+49.27%

Mr. Michael J. Harrington

Independent Director

109.58K

--

Mr. Art A. Garcia, CPA

Independent Director

91.28K

--

Dr. Deborah Turner Kochevar, Ph.D.

Independent Director

89.71K

--

Mr. Paul S. Herendeen

Independent Director

84.81K

--

Ms. Shiv O'Neill

Executive Vice President, General Counsel, Corporate Secretary

83.83K

+35.69%

Mr. James Meer

Senior Vice President, Chief Accounting Officer

71.18K

+12.12%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

3.25M

+27.46%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

229.43K

+10.35%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

170.34K

--

Mr. Timothy J. (Tim) Bettington

Executive Vice President - Corporate Strategy and Market Development

158.49K

+49.27%

Mr. Michael J. Harrington

Independent Director

109.58K

--

Mr. Art A. Garcia, CPA

Independent Director

91.28K

--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por EmpresaUSD

Nome

Receita

Proporção

Farm Animal

2.36B

50.10%

Pet Health

2.30B

48.78%

Contract Manufacturing

53.00M

1.12%

Por RegiãoUSD

Nome

Receita

Proporção

International

2.48B

52.62%

United States

2.23B

47.38%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Farm Animal

2.36B

50.10%

Pet Health

2.30B

48.78%

Contract Manufacturing

53.00M

1.12%

Distribuição de ações

Atualizado em: há 11 horas

Investidores

Tipos de investidores

Investidores

Proporção

Dodge & Cox

15.83%

PRIMECAP Management Company

9.25%

BlackRock Institutional Trust Company, N.A.

8.17%

Fidelity Management & Research Company LLC

7.82%

T. Rowe Price Investment Management, Inc.

7.05%

Outro

51.87%

Investidores

Proporção

Dodge & Cox

15.83%

PRIMECAP Management Company

9.25%

BlackRock Institutional Trust Company, N.A.

8.17%

Fidelity Management & Research Company LLC

7.82%

T. Rowe Price Investment Management, Inc.

7.05%

Outro

51.87%

Tipos de investidores

Investidores

Proporção

Investment Advisor

74.55%

Investment Advisor/Hedge Fund

36.56%

Hedge Fund

4.40%

Research Firm

1.99%

Individual Investor

1.29%

Pension Fund

1.13%

Bank and Trust

0.67%

Sovereign Wealth Fund

0.29%

Family Office

0.12%

Participação acionária institucional



Atualizado em: qua, 1 de abr

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2026Q1

950

549.30M

109.98%

-60.07M

2025Q4

852

577.24M

120.43%

+30.91K

2025Q3

891

577.57M

121.95%

+32.95M

2025Q2

878

543.55M

113.98%

+36.20M

2025Q1

945

503.90M

116.31%

-73.53M

2024Q4

964

498.16M

117.36%

+7.74M

2024Q3

970

490.73M

118.81%

+19.54K

2024Q2

1004

491.01M

118.24%

+1.27M

2024Q1

1021

489.85M

119.72%

-100.34M

2023Q4

1018

489.74M

120.73%

-3.72M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

Dodge & Cox

79.08M

15.91%

-3.68M

-4.44%

Dec 31, 2025

PRIMECAP Management Company

46.21M

9.3%

-3.74M

-7.49%

Dec 31, 2025

BlackRock Institutional Trust Company, N.A.

40.81M

8.21%

+388.49K

+0.96%

Dec 31, 2025

Fidelity Management & Research Company LLC

39.05M

7.86%

-11.69M

-23.03%

Dec 31, 2025

T. Rowe Price Investment Management, Inc.

35.23M

7.09%

+3.72M

+11.80%

Dec 31, 2025

Dimensional Fund Advisors, L.P.

25.08M

5.05%

+373.87K

+1.51%

Dec 31, 2025

State Street Investment Management (US)

15.05M

3.03%

-195.25K

-1.28%

Dec 31, 2025

Fidelity Institutional Asset Management

12.16M

2.45%

-67.80K

-0.55%

Dec 31, 2025

Ver Mais

ETFs Relacionados



Atualizado em: sáb, 6 de dez

Nome

Proporção

iShares U.S. Pharmaceuticals ETF

4.06%

Adaptiv Select ETF

3.38%

State Street SPDR S&P Pharmaceuticals ETF

3.15%

Brandes US Small-Mid Cap Value ETF

3.14%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

2.84%

VanEck Agribusiness ETF

2.3%

First Trust Health Care Alphadex Fund

1.92%

Federated Hermes MDT Large Cap Value ETF

1.9%

First Trust NASDAQ Pharmaceuticals ETF

1.33%

Invesco S&P MidCap 400 Pure Value ETF

1.22%

Ver Mais

iShares U.S. Pharmaceuticals ETF

Proporção4.06%

Adaptiv Select ETF

Proporção3.38%

State Street SPDR S&P Pharmaceuticals ETF

Proporção3.15%

Brandes US Small-Mid Cap Value ETF

Proporção3.14%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

Proporção2.84%

VanEck Agribusiness ETF

Proporção2.3%

First Trust Health Care Alphadex Fund

Proporção1.92%

Federated Hermes MDT Large Cap Value ETF

Proporção1.9%

First Trust NASDAQ Pharmaceuticals ETF

Proporção1.33%

Invesco S&P MidCap 400 Pure Value ETF

Proporção1.22%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Data ex-dividendo

Tipo

Proporção

Sem dados

Data

Data ex-dividendo

Tipo

Proporção

Sem dados